# Charco Neurotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/charco-neurotech

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.charconeurotech.com
- Total disclosed funding: $11M
- Latest round: Seed (Nov 16, 2021)
- Investors on record: 5

## About

Charco Neurotech Ltd. is a London-based company focused on creating innovative wearable devices for individuals suffering from Parkinson's disease, aiming to improve their mobility and quality of life.Founded in 2019, Charco Neurotech Ltd. specializes in non-invasive solutions for Parkinson's disease management. The firm has completed 4 deals, with its most recent funding round, a Seed investment of GBP 7.4 mn on November 16, 2021, led by Amadeus Capital Partners and other partners. The CEO, Lucy Jung, is supported by co-founders Abdul A., Floyd Pierres, Lorena Canelas, and Lucy Jung herself. The company's headquarters is located in London, UK.Charco Neurotech designs non-invasive wearable devices tailored for individuals with Parkinson's disease. Their primary product, the CUE Device, utilizes pulsed cueing and high-frequency focused vibrotactile stimulation to address symptoms like slowness and rigidity. The device serves over 3,000 users globally and can operate independently or with the CUE app for personalized settings and symptom tracking. Key markets include North America, Europe, and parts of Asia, where innovative Parkinson's management solutions are in high demand.Charco Neurotech generates revenue through direct-to-consumer sales of the CUE Device and CUE app. The CUE1+ device is positioned at a competitive price point to ensure accessibility for patients. The company may also collaborate with healthcare professionals for broader distribution. Additionally, the app includes subscription features for enhanced support in symptom management, contributing to a sustainable business model.Following the Seed funding of GBP 4.7 mn raised in November 2021, Charco Neurotech plans to expand its team to ensure users maximize their benefits from the CUE1. The company is focused on broadening its market presence, particularly aiming for expansion into additional regions within Europe and North America by the end of 2023. This funding will facilitate the setup process for users, enhancing their experience with the CUE1 device.

## Funding rounds

- Seed, Nov 16, 2021, $10M — Amadeus Capital Partners, University of Tokyo Edge Capital Partners, Parkwalk Advisors, Crista Galli Ventures, Mint Venture Partners
- Seed, Mar 1, 2021, $0.8M — Crista Galli Ventures

## Investors

- Crista Galli Ventures (https://capitalatlas.ai/funds/crista-galli-ventures) — Seed
- Amadeus Capital Partners (https://capitalatlas.ai/funds/amadeus-capital-partners) — Seed
- University of Tokyo Edge Capital Partners (https://capitalatlas.ai/funds/university-of-tokyo-edge-capital-partners) — Seed
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Seed
- Mint Venture Partners (https://capitalatlas.ai/funds/mint-venture-partners) — Seed